Ryan Hutten, MD
Radiation Oncology · Madison, WINPI 1447754395
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,214 of the $1,937 with a category attached, or 62.7%. Bioprotect Medical, Inc. accounts for 68.7% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $1,332, more than ten times the $29 reported in 2021.
Across 7 payments — averaging $276.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bioprotect Medical, Inc.$1K
- Elekta, Inc.$174
- Reflexion Medical, Inc.$166
- Zap Surgical Systems, Inc.$126
- Novocure Inc.$110
- Boston Scientific$29
What the payments were for
- Travel & lodging$1,21463%
- Food & beverage$72437%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bioprotect Medical, Inc. | 2 | $1,332 |
| Elekta, Inc. | 1 | $174 |
| Reflexion Medical, Inc. | 1 | $166 |
| Zap Surgical Systems, Inc. | 1 | $126 |
| Novocure Inc. | 1 | $110 |
| Boston Scientific | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,937 in reported general payments places this provider in the 85th percentile of 131 radiation oncology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 65 | $163,358 |
| Tamsulosin Hcl | 63 | $712 |
| Bicalutamide | 15 | $219 |
| Ciprofloxacin Hcl | 23 | $44 |
| Lorazepam | 17 | $18 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Madison
- Timothy KruserMadison$235K
- Stephen RosenbergMadison$18K
- Matthew WitekMadison$11K
- Micheal BassettiMadison$1K
- Brett MorrisMadison$1K
- Zachary MorrisMadison$1K
- Benjamin DurkeeMadison$1K
- Paul HarariMadison$861
- Bethany AndersonMadison$725
- Pippa CosperMadison$636
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.